1932

Abstract

Abstract

Tumors, wounds, and chronic inflammatory disorders generate a new vascular supply by a process known as pathological angiogenesis. Whereas formation of the normal blood vasculature requires the interaction of many different agonists and inhibitors, including vascular endothelial growth factor-A (VEGF-A) and other members of the vascular permeability factor/VEGF family, pathological angiogenesis is a cruder, simpler process that can be replicated by a single VEGF-A isoform, VEGF-A164/5. VEGF-A164/5 induces the formation of several distinctly different types of new blood vessels that differ from normal blood vessels with respect to organization, structure, and function. Elucidating the properties of these new vessels has led to a better understanding of angiogenesis and will hopefully lead to new approaches to antiangiogenic therapy.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.pathol.2.010506.134925
2007-02-28
2024-07-19
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.pathol.2.010506.134925
Loading
/content/journals/10.1146/annurev.pathol.2.010506.134925
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error